SEMMELWEIS UNIVERSITY, DEPARTMENT OF UROLOGY
TOPIC
Urology – Oncology
VISION
Therapy optimization of urothelial cancers.
MISSION
Utilization of biomarkers in urothelial cancers treated with immune checkpoint inhibitors.
SPECIFIC GOALS
- PROJECT 1: Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
- PROJECT 2: High pretreatment sPD-L1 is associated with muscle-invasion and shorter survival in upper tract urothelial carcinoma (UTUC): a post hoc analysis of a prospectively collected serum samples.